NeuroScientific Biopharmaceuticals Limited’s (ASX:NSB) Share Price Boosted 29% But Its Business Prospects Need A Lift Too
Despite an already strong run, NeuroScientific Biopharmaceuticals Limited (ASX:NSB) shares have been powering on, with a gain of 29% in the last thirty days. The last 30 days bring the annual gain to a very sharp 68%.
Even after such a large jump in price, NeuroScientific Biopharmaceuticals may still be sending very bullish signals at the moment with its price-to-earnings (or “P/E”) ratio of 8.2x, since almost half of all companies in Australia have P/E ratios greater than 19x and even P/E’s higher than 33x are not unusual. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the highly reduced P/E.
This technology could replace computers: discover the 20 stocks are working to make…
